Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results And New Data Reinforcing Strategic Focus In Kidney Disease
Stay updated with breaking news from Manuela Bader. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024 Halle / Munich, Germany, May 15, 2024 - Vivoryon Therapeutics N.V. , a clinical stage...
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Half Year Results Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational Progress
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Capital Increase Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Successful Private Placement of up to EUR 30 Million (news
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report H1 2022 Financial Results and Operational Progress on September